{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T21:20:07Z","timestamp":1783545607754,"version":"3.55.0"},"reference-count":244,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>The B subunit pentamer verotoxin (VT aka Shiga toxin-Stx) binding to its cellular glycosphingolipid (GSL) receptor, globotriaosyl ceramide (Gb3) mediates internalization and the subsequent receptor mediated retrograde intracellular traffic of the AB5 subunit holotoxin to the endoplasmic reticulum. Subunit separation and cytosolic A subunit transit via the ER retrotranslocon as a misfolded protein mimic, then inhibits protein synthesis to kill cells, which can cause hemolytic uremic syndrome clinically. This represents one of the most studied systems of prokaryotic hijacking of eukaryotic biology. Similarly, the interaction of cholera AB5 toxin with its GSL receptor, GM1 ganglioside, is the key component of the gastrointestinal pathogenesis of cholera and follows the same retrograde transport pathway for A subunit cytosol access. Although both VT and CT are the cause of major pathology worldwide, the toxin\u2013receptor interaction is itself being manipulated to generate new approaches to control, rather than cause, disease. This arena comprises two areas: anti neoplasia, and protein misfolding diseases. CT\/CTB subunit immunomodulatory function and anti-cancer toxin immunoconjugates will not be considered here. In the verotoxin case, it is clear that Gb3 (and VT targeting) is upregulated in many human cancers and that there is a relationship between GSL expression and cancer drug resistance. While both verotoxin and cholera toxin similarly hijack the intracellular ERAD quality control system of nascent protein folding, the more widespread cell expression of GM1 makes cholera the toxin of choice as the means to more widely utilise ERAD targeting to ameliorate genetic diseases of protein misfolding. Gb3 is primarily expressed in human renal tissue. Glomerular endothelial cells are the primary VT target but Gb3 is expressed in other endothelial beds, notably brain endothelial cells which can mediate the encephalopathy primarily associated with VT2-producing E. coli infection. The Gb3 levels can be regulated by cytokines released during EHEC infection, which complicate pathogenesis. Significantly Gb3 is upregulated in the neovasculature of many tumours, irrespective of tumour Gb3 status. Gb3 is markedly increased in pancreatic, ovarian, breast, testicular, renal, astrocytic, gastric, colorectal, cervical, sarcoma and meningeal cancer relative to the normal tissue. VT has been shown to be effective in mouse xenograft models of renal, astrocytoma, ovarian, colorectal, meningioma, and breast cancer. These studies are herein reviewed. Both CT and VT (and several other bacterial toxins) access the cell cytosol via cell surface -&gt;ER transport. Once in the ER they interface with the protein folding homeostatic quality control pathway of the cell -ERAD, (ER associated degradation), which ensures that only correctly folded nascent proteins are allowed to progress to their cellular destinations. Misfolded proteins are translocated through the ER membrane and degraded by cytosolic proteosome. VT and CT A subunits have a C terminal misfolded protein mimic sequence to hijack this transporter to enter the cytosol. This interface between exogenous toxin and genetically encoded endogenous mutant misfolded proteins, provides a new therapeutic basis for the treatment of such genetic diseases, e.g., Cystic fibrosis, Gaucher disease, Krabbe disease, Fabry disease, Tay-Sachs disease and many more. Studies showing the efficacy of this approach in animal models of such diseases are presented.<\/jats:p>","DOI":"10.3390\/toxins13060378","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T21:56:44Z","timestamp":1622066204000},"page":"378","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Therapeutic Uses of Bacterial Subunit Toxins"],"prefix":"10.3390","volume":"13","author":[{"given":"Clifford","family":"Lingwood","sequence":"first","affiliation":[{"name":"Division of Molecular Medicine, Research Institute, Hospital for Sick Children, Toronto, ON M5G 1X8, Canada"},{"name":"Departments of Laboratory Medicine & Pathobiology, and Biochemistry, University of Toronto, Toronto, ON M5S 1A8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/infdis\/151.5.775","article-title":"The Association between Idiopathic Hemolytic Uremic Syndrome and Infection by Verotoxin-Producing Escherichia coli","volume":"151","author":"Karmali","year":"1985","journal-title":"J. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1182\/blood-2016-11-709865","article-title":"HUS and atypical HUS","volume":"129","author":"Jokiranta","year":"2017","journal-title":"Blood"},{"key":"ref_3","first-page":"299","article-title":"Escherichia coli Shiga toxin","volume":"9","author":"Nakao","year":"2000","journal-title":"J. Nat. Toxins"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s004670100660","article-title":"Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome","volume":"16","author":"Ray","year":"2001","journal-title":"Pediatr. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1007\/s00467-018-4105-1","article-title":"Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS)","volume":"34","author":"Khalid","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1128\/JCM.37.3.497-503.1999","article-title":"Associations between Virulence Factors of Shiga Toxin-ProducingEscherichia coli and Disease in Humans","volume":"37","author":"Boerlin","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s10096-003-1025-0","article-title":"Strong Association Between Shiga Toxin-Producing Escherichia coli O157 and Virulence Genes stx 2 and eae as Possible Explanation for Predominance of Serogroup O157 in Patients with Haemolytic Uraemic Syndrome","volume":"22","author":"Werber","year":"2003","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1128\/JCM.00420-14","article-title":"Characterization of Enterohemorrhagic Escherichia coli O111 and O157 Strains Isolated from Outbreak Patients in Japan","volume":"52","author":"Watahiki","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"8834","DOI":"10.1016\/S0021-9258(18)47490-X","article-title":"Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro","volume":"262","author":"Lingwood","year":"1987","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1074\/jbc.M600057200","article-title":"Targeted Disruption of Gb3\/CD77 Synthase Gene Resulted in the Complete Deletion of Globo-series Glycosphingolipids and Loss of Sensitivity to Verotoxins","volume":"281","author":"Okuda","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00292-008-1040-0","article-title":"Glycosphingolipids Gb3 and iGb3. In vivo roles in hemolytic-uremic syndrome and iNKT cell function","volume":"29","author":"Porubsky","year":"2008","journal-title":"Pathologe"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"42915","DOI":"10.1074\/jbc.M106015200","article-title":"Kinetic Analysis of Binding between Shiga Toxin and Receptor Glycolipid Gb3Cer by Surface Plasmon Resonance","volume":"276","author":"Nakajima","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/ki.2009.7","article-title":"Detergent-resistant globotriaosyl ceramide may define verotoxin\/glomeruli-restricted hemolytic uremic syndrome pathology","volume":"75","author":"Khan","year":"2009","journal-title":"Kidney Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1126\/science.1174621","article-title":"Lipid Rafts as a Membrane-Organizing Principle","volume":"327","author":"Lingwood","year":"2009","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/biot.201100360","article-title":"Lipid rafts generate digital-like signal transduction in cell plasma membranes","volume":"7","author":"Suzuki","year":"2012","journal-title":"Biotechnol. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"R823","DOI":"10.1016\/S0960-9822(00)00788-0","article-title":"Microbial pathogenesis: Lipid rafts as pathogen portals","volume":"10","author":"Rosenberger","year":"2000","journal-title":"Curr. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1128\/IAI.74.1.28-39.2006","article-title":"Role of Sphingolipids in Microbial Pathogenesis","volume":"74","author":"Heung","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Utskarpen, A., Massol, R., Van Deurs, B., Lauvrak, S.U., Kirchhausen, T., and Sandvig, K. (2010). Shiga Toxin Increases Formation of Clathrin-Coated Pits through Syk Kinase. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010944"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1111\/j.1742-4658.2005.04835.x","article-title":"The A-subunit of surface-bound Shiga toxin stimulates clathrin-dependent uptake of the toxin","volume":"272","author":"Torgersen","year":"2005","journal-title":"FEBS J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/jcp.1041610217","article-title":"Capping and receptor-mediated endocytosis of cell-bound verotoxin (shiga-like toxin) 1: Chemical identification of an amino acid in the B subunit necessary for efficient receptor glycolipid binding and cellular internalization","volume":"161","author":"Khine","year":"1994","journal-title":"J. Cell. Physiol."},{"key":"ref_21","first-page":"670","article-title":"Shiga toxin induces tubular membrane invaginations for its uptake into cells","volume":"450","author":"Berland","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"ref_22","first-page":"493","article-title":"Endophilin-A2 functions in membrane scission in clathrin-independent endocytosis","volume":"517","author":"Renard","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Johannes, L. (2017). Shiga Toxin\u2014A Model for Glycolipid-Dependent and Lectin-Driven Endocytosis. Toxins, 9.","DOI":"10.3390\/toxins9110340"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1091\/mbc.12.8.2453","article-title":"Targeting of Shiga Toxin B-Subunit to Retrograde Transport Route in Association with Detergent-resistant Membranes","volume":"12","author":"Mallard","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00467-017-3850-x","article-title":"Shiga toxin triggers endothelial and podocyte injury: The role of complement activation","volume":"34","author":"Zoja","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Detzner, J., Gloerfeld, C., Pohlentz, G., Legros, N., Humpf, H.-U., Mellmann, A., Karch, H., and M\u00fcthing, J. (2019). Structural Insights into Escherichia coli Shiga Toxin (Stx) Glycosphingolipid Receptors of Porcine Renal Epithelial Cells and Inhibition of Stx-Mediated Cellular Injury Using Neoglycolipid-Spiked Glycovesicles. Microorganisms, 7.","DOI":"10.3390\/microorganisms7110582"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1021\/acs.jctc.0c01145","article-title":"Multiscale Molecular Dynamics Studies Reveal Different Modes of Receptor Clustering by Gb3-Binding Lectins","volume":"17","author":"Kociurzynski","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.toxicon.2009.11.021","article-title":"Endocytosis and retrograde transport of Shiga toxin","volume":"56","author":"Sandvig","year":"2010","journal-title":"Toxicon"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"11051","DOI":"10.1021\/bi971383p","article-title":"Accumulating Evidence Suggests That Several AB-Toxins Subvert the Endoplasmic Reticulum-Associated Protein Degradation Pathway To Enter Target Cells","volume":"36","author":"Hazes","year":"1997","journal-title":"Biochemistry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"9325","DOI":"10.1021\/bi960177z","article-title":"Insertion and Orientation of a Synthetic Peptide Representing the C-Terminus of the A1Domain of Shiga Toxin into Phospholipid Membranes","volume":"35","author":"Saleh","year":"1996","journal-title":"Biochemistry"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Nowakowska-Go\u0142acka, J., Sominka, H., Sowa-Rogozi\u0144ska, N., and S\u0142omi\u0144ska-Wojew\u00f3dzka, M. (2019). Toxins Utilize the Endoplasmic Reticulum-Associated Protein Degradation Pathway in Their Intoxication Process. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061307"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"a013185","DOI":"10.1101\/cshperspect.a013185","article-title":"The Mammalian Endoplasmic Reticulum-Associated Degradation System","volume":"5","author":"Olzmann","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0041-0101(96)00225-5","article-title":"The RNA-N-glycosidase activity of Shiga-like toxin I: Kinetic parameters of the native and activated toxin","volume":"35","author":"Brigotti","year":"1997","journal-title":"Toxicon"},{"key":"ref_34","first-page":"19","article-title":"How ricin and Shiga toxin reach the cytosol of target cells: Retrotranslocation from the endoplasmic reticulum","volume":"357","author":"Spooner","year":"2012","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1091\/mbc.e03-06-0354","article-title":"Gangliosides that associate with lipid rafts mediate transport of cholera and related toxins from the plasma membrane to ER","volume":"14","author":"Fujinaga","year":"2003","journal-title":"Mol. Biol. Cell."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbamcr.2005.07.007","article-title":"Raft trafficking of AB5 subunit bacterial toxins","volume":"1746","author":"Lencer","year":"2005","journal-title":"Biochim. Biophys. Acta (BBA) Bioenerg."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Lopata, A., Kniss, A., L\u00f6hr, F., Rogov, V.V., and D\u00f6tsch, V. (2020). Ubiquitination in the ERAD Process. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155369"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"20084","DOI":"10.1074\/jbc.RA119.010019","article-title":"A technique for delineating the unfolding requirements for substrate entry into retrotranslocons during endoplasmic reticulum\u2013associated degradation","volume":"294","author":"Shi","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_39","first-page":"432","article-title":"Sec6l-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction","volume":"384","author":"Wiertz","year":"1996","journal-title":"Nat. Cell Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1038\/emboj.2009.231","article-title":"Sec61p is part of the endoplasmic reticulum-associated degradation machinery","volume":"28","author":"Wolf","year":"2009","journal-title":"EMBO J."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Kaiser, M.-L., and R\u00f6misch, K. (2015). Proteasome 19S RP Binding to the Sec61 Channel Plays a Key Role in ERAD. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0117260"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.tibs.2016.10.005","article-title":"A Case for Sec61 Channel Involvement in ERAD","volume":"42","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1091\/mbc.e07-08-0755","article-title":"Derlin-1 Facilitates the Retro-Translocation of Cholera Toxin","volume":"19","author":"Bernardi","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1083\/jcb.200507057","article-title":"Derlin-2 and Derlin-3 are regulated by the mammalian unfolded protein response and are required for ER-associated degradation","volume":"172","author":"Oda","year":"2006","journal-title":"J. Cell Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.biocel.2010.12.021","article-title":"Different p97\/VCP complexes function in retrotranslocation step of mammalian Er-associated degradation (ERAD)","volume":"43","author":"Ballar","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"14710","DOI":"10.1074\/jbc.M809607200","article-title":"In vitro analysis of Hrd1p-mediated retrotranslocation of its multispanning membrane substrate 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase","volume":"284","author":"Garza","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.201203061","article-title":"Aberrant substrate engagement of the ER translocon triggers degradation by the Hrd1 ubiquitin ligase","volume":"197","author":"Rubenstein","year":"2012","journal-title":"J. Cell Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"E582","DOI":"10.1073\/pnas.1318114111","article-title":"Sel1L is indispensable for mammalian endoplasmic reticulum-associated degradation, endoplasmic reticulum homeostasis, and survival","volume":"111","author":"Sun","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41556-020-0473-4","article-title":"Hrd1 forms the retrotranslocation pore regulated by auto-ubiquitination and binding of misfolded proteins","volume":"22","author":"Vasic","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Li, S., Spooner, R.A., Hampton, R.Y., Lord, J.M., and Roberts, L.M. (2012). Cytosolic Entry of Shiga-Like Toxin A Chain from the Yeast Endoplasmic Reticulum Requires Catalytically Active Hrd1p. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0041119"},{"key":"ref_51","first-page":"149","article-title":"Entry of Protein Toxins into Mammalian Cells by Crossing the Endoplasmic Reticulum Membrane: Co-opting Basic Mechanisms of Endoplasmic Reticulum-Associated Degradation","volume":"300","author":"Lord","year":"2005","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.1128\/IAI.70.11.6166-6171.2002","article-title":"Transfer of the Cholera Toxin A1 Polypeptide from the Endoplasmic Reticulum to the Cytosol Is a Rapid Process Facilitated by the Endoplasmic Reticulum-Associated Degradation Pathway","volume":"70","author":"Teter","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3181\/0705-RM-132","article-title":"Cholera Toxin Up-Regulates Endoplasmic Reticulum Proteins That Correlate with Sensitivity to the Toxin","volume":"233","author":"Dixit","year":"2008","journal-title":"Exp. Biol. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1182\/blood.V90.7.2757","article-title":"Intracellular signaling events in CD77-mediated apoptosis of Burkitt\u2019s lymphoma cells","volume":"90","author":"Taga","year":"1997","journal-title":"Blood"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1046\/j.1523-1755.1998.00939.x","article-title":"Verotoxins induce apoptosis in human renal tubular epithelium derived cells","volume":"53","author":"Taguchi","year":"1998","journal-title":"Kidney Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1128\/IAI.66.2.636-644.1998","article-title":"Apoptosis of Renal Cortical Cells in the Hemolytic-Uremic Syndrome: In Vivo and In Vitro Studies","volume":"66","author":"Karpman","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1348-0421.2002.tb02753.x","article-title":"A Novel Caspase Dependent Pathway Is Involved in Apoptosis of Human Endothelial Cells by Shiga Toxins","volume":"46","author":"Yoshida","year":"2002","journal-title":"Microbiol. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1128\/IAI.70.8.4669-4677.2002","article-title":"Escherichia coli Shiga-Like Toxins Induce Apoptosis and Cleavage of Poly(ADP-Ribose) Polymerase via In Vitro Activation of Caspases","volume":"70","author":"Ching","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/sj.bjp.0705560","article-title":"Verotoxin activates mitogen-activated protein kinase in human peripheral blood monocytes: Role in apoptosis and proinflammatory cytokine release","volume":"140","author":"Cameron","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1128\/IAI.01581-07","article-title":"Shiga Toxin 2 Causes Apoptosis in Human Brain Microvascular Endothelial Cells via C\/EBP Homologous Protein","volume":"76","author":"Fujii","year":"2008","journal-title":"Infect. Immun."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1462-5822.2007.01083.x","article-title":"Shiga toxin 1 induces apoptosis through the endoplasmic reticulum stress response in human monocytic cells","volume":"10","author":"Lee","year":"2008","journal-title":"Cell. Microbiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1038\/s41388-018-0123-5","article-title":"Differential role of FL-BID and t-BID during verotoxin-1-induced apoptosis in Burkitt\u2019s lymphoma cells","volume":"37","author":"Debernardi","year":"2018","journal-title":"Oncogene"},{"key":"ref_63","first-page":"5314","article-title":"Apoptosis induced in Burkitt\u2019s lymphoma cells via Gb3\/CD77, a glycolipid antigen","volume":"53","author":"Mangeney","year":"1993","journal-title":"Cancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1046\/j.1365-2958.1999.01564.x","article-title":"Regulated expression of the Shiga toxin B gene induces apoptosis in mammalian fibroblastic cells","volume":"33","author":"Nakagawa","year":"2002","journal-title":"Mol. Microbiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"19087","DOI":"10.1073\/pnas.0506474102","article-title":"The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer","volume":"102","author":"Kovbasnjuk","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"45200","DOI":"10.1074\/jbc.M303868200","article-title":"Two distinct Gb3\/CD77 signaling pathways leading to apoptosis are triggered by anti-Gb3\/CD77 mAb and verotoxin-1","volume":"278","author":"Carlier","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"152531","DOI":"10.1016\/j.tox.2020.152531","article-title":"Transcriptional network inference and master regulator analysis of the response to ribosome-inactivating proteins in leukemia cells","volume":"441","author":"Mercatelli","year":"2020","journal-title":"Toxicology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0301-472X(00)00538-5","article-title":"Globotriaosyl ceramide (CD77\/Gb3) in the glycolipid-enriched membrane domain participates in B-cell receptor-mediated apoptosis by regulating lyn kinase activity in human B cells","volume":"28","author":"Mori","year":"2000","journal-title":"Exp. Hematol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1128\/IAI.71.5.2724-2735.2003","article-title":"Rapid Apoptosis Induced by Shiga Toxin in HeLa Cells","volume":"71","author":"Fujii","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e12607","DOI":"10.1111\/cpr.12607","article-title":"Shiga-like toxin I exerts specific and potent anti-tumour efficacy against gastric cancer cell proliferation when driven by tumour-preferential Frizzled-7 promoter","volume":"52","author":"Xu","year":"2019","journal-title":"Cell Prolif."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.4161\/cbt.5.9.3173","article-title":"Verotoxin-1 induction of apoptosis in Gb3-expressing human glioma cell lines","volume":"5","author":"Johansson","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Johansson, D., Kosovac, E., Moharer, J., Ljuslinder, I., Br\u00e4nnstr\u00f6m, T., Johansson, A., and Behnam-Motlagh, P. (2009). Expression of verotoxin-1 receptor Gb3 in breast cancer tissue and verotoxin-1 signal transduction to apoptosis. BMC Cancer, 9.","DOI":"10.1186\/1471-2407-9-67"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Debernardi, J., Pioche-Durieu, C., Le Cam, E., Wiels, J., and Robert, A. (2020). Verotoxin-1-Induced ER Stress Triggers Apoptotic or Survival Pathways in Burkitt Lymphoma Cells. Toxins, 12.","DOI":"10.3390\/toxins12050316"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/oxfordjournals.jbchem.a133015","article-title":"Blood Group Type Glycosphingolipids of Human Cord Blood Erythrocytes1","volume":"88","author":"Larson","year":"1980","journal-title":"J. Biochem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1744-313X.1980.tb00738.x","article-title":"A new pkphenotype in the p blood group system","volume":"7","author":"Kundu","year":"1980","journal-title":"Eur. J. Immunogenet."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"6485","DOI":"10.1073\/pnas.78.10.6485","article-title":"Monoclonal antibody against a Burkitt lymphoma-associated antigen","volume":"78","author":"Wiels","year":"1981","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_77","first-page":"293","article-title":"A monoclonal antibody, specific for Burkitt\u2019s lymphoma, is also a blood group Pk antibody","volume":"57","author":"Fellous","year":"1984","journal-title":"Dev. Boil. Stand."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ijc.2910360407","article-title":"Induction of cell differentiation in burkitt lymphoma lines. BLA: A glycolipid marker of B-cell differentiation","volume":"36","author":"Balana","year":"1985","journal-title":"Int. J. Cancer"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/eji.1830210507","article-title":"CD77: An antigen of germinal center B cells entering apoptosis","volume":"21","author":"Mangeney","year":"1991","journal-title":"Eur. J. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF00389971","article-title":"Distribution of the Burkitt\u2019s-lymphoma-associated antigen (BLA) in normal human tissue and malignant lymphoma as defined by immunohistological staining with monoclonal antibody 38.13","volume":"113","author":"Pallesen","year":"1987","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1021\/acs.analchem.0c00480","article-title":"MALDI-2 Mass Spectrometry and Immunohistochemistry Imaging of Gb3Cer, Gb4Cer, and Further Glycosphingolipids in Human Colorectal Cancer Tissue","volume":"92","author":"Bien","year":"2020","journal-title":"Anal. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3389\/fonc.2020.00732","article-title":"Differential O- and Glycosphingolipid Glycosylation in Human Pancreatic Adenocarcinoma Cells With Opposite Morphology and Metastatic Behavior","volume":"10","author":"Zhang","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Stimmer, L., Dehay, S., Nemati, F., Massonnet, G., Richon, S., Decaudin, D., Klijanienko, J., and Johannes, L. (2014). Human breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-916"},{"key":"ref_84","first-page":"553","article-title":"Expression of the verotoxin receptor glycolipid, globotriaosylceramide, in ovarian hyperplasias","volume":"9","author":"Arab","year":"1997","journal-title":"Oncol. Res. Featur. Preclin. Clin. Cancer Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"6996","DOI":"10.1073\/pnas.92.15.6996","article-title":"The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1","volume":"92","author":"Hill","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"6505","DOI":"10.1021\/bi00525a032","article-title":"Neutral glycospingolipids in hairy cell leukemia","volume":"20","author":"Lee","year":"1981","journal-title":"Biochemistry"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"11247","DOI":"10.1074\/jbc.M109519200","article-title":"Expression of the Gb3\/CD77 synthase gene in megakaryoblastic leukemia cells: Implication in the sensitivity to verotoxins","volume":"277","author":"Furukawa","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_88","first-page":"2901","article-title":"Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: Implications for ex vivo tumor purging and autologous stem cell transplantation","volume":"94","author":"Lacasse","year":"1999","journal-title":"Blood"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0145-2126(00)00060-6","article-title":"Verotoxin targets lymphoma infiltrates of patients with post-transplant lymphoproliferative disease","volume":"24","author":"Arbus","year":"2000","journal-title":"Leuk. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/01.ju.0000100110.11129.85","article-title":"Verotoxin Induces Rapid Elimination of Human Renal Tumor Xenografts in SCID Mice","volume":"171","author":"Ishitoya","year":"2004","journal-title":"J. Urol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1158\/1535-7163.MCT-08-0430","article-title":"Human colorectal tumors and metastases express Gb3 and can be targeted by an intestinal pathogen-based delivery tool","volume":"7","author":"Maak","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1158\/1535-7163.MCT-15-0633","article-title":"Gastric Adenocarcinomas Express the Glycosphingolipid Gb3\/CD77: Targeting of Gastric Cancer Cells with Shiga Toxin B-Subunit","volume":"15","author":"Geyer","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/ijc.2910450610","article-title":"Changes in glycolipid expression in human testicular tumor","volume":"45","author":"Ohyama","year":"1990","journal-title":"Int. J. Cancer"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Distler, U., Souady, J., H\u00fclsewig, M., Drmi\u0107-Hofman, I., Haier, J., Friedrich, A.W., Karch, H., Senninger, N., Dreisewerd, K., and Berkenkamp, S. (2009). Shiga Toxin Receptor Gb3Cer\/CD77: Tumor-Association and Promising Therapeutic Target in Pancreas and Colon Cancer. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006813"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1158\/1535-7163.MCT-11-0006","article-title":"Tumor-Specific Targeting of Pancreatic Cancer with Shiga Toxin B-Subunit","volume":"10","author":"Maak","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1515\/hsz-2012-0165","article-title":"Shiga toxin glycosphingolipid receptor expression and toxin susceptibility of human pancreatic ductal adenocarcinomas of differing origin and differentiation","volume":"393","author":"Storck","year":"2012","journal-title":"Biol. Chem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1042\/bj2400925","article-title":"Accumulation of globotriaosylceramide in a case of leiomyosarcoma","volume":"240","author":"Li","year":"1986","journal-title":"Biochem. J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1023\/A:1006010019064","article-title":"Verotoxins inhibit the growth of and induce apoptosis in human astrocytoma cells","volume":"40","author":"Arab","year":"1998","journal-title":"J. Neuro Oncol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1040-8428(01)00126-3","article-title":"The use of Shiga-like toxin 1 in cancer therapy","volume":"39","year":"2001","journal-title":"Crit. Rev. Oncol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.neo.7900243","article-title":"The Treatment of Malignant Meningioma with Verotoxin","volume":"4","author":"Salhia","year":"2002","journal-title":"Neoplasia"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2310\/7290.2010.00030","article-title":"Tumor Delivery of Ultrasound Contrast Agents Using Shiga Toxin B Subunit","volume":"10","author":"Couture","year":"2011","journal-title":"Mol. Imaging"},{"key":"ref_102","first-page":"33","article-title":"Verotoxin induces apoptosis and the complete, rapid, long-term elimination of human astrocytoma xenografts in nude mice","volume":"11","author":"Arab","year":"1999","journal-title":"Oncol. Res. Featur. Preclin. Clin. Cancer Ther."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2310\/7290.2008.00022","article-title":"In Vivo Tumor Targeting by the B-Subunit of Shiga Toxin","volume":"7","author":"Viel","year":"2008","journal-title":"Mol. Imaging"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1023\/B:AGEN.0000011799.47529.fd","article-title":"Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumour model: VT1 as a tumour neovascular marker","volume":"6","author":"Lingwood","year":"2003","journal-title":"Angiogenesis"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Desselle, A., Chaumette, T., Gaugler, M.-H., Cochonneau, D., Fleurence, J., Dubois, N., Hulin, P., Aubry, J., Birkl\u00e9, S., and Paris, F. (2012). Anti-Gb3 Monoclonal Antibody Inhibits Angiogenesis and Tumor Development. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0045423"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e23700","DOI":"10.4161\/onci.23700","article-title":"Inhibition of tumor angiogenesis by globotriaosylceramide immunotargeting","volume":"2","author":"Desselle","year":"2013","journal-title":"Oncoimmunology"},{"key":"ref_107","first-page":"6480","article-title":"Decreased accessibility of globotriaosylceramide associated with decreased tumorigenicity in Burkitt\u2019s lymphoma variants induced by immunoselection","volume":"49","author":"Junqua","year":"1989","journal-title":"Cancer Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00249-020-01461-w","article-title":"Chemically synthesized Gb3 glycosphingolipids: Tools to access their function in lipid membranes","volume":"50","author":"Sibold","year":"2021","journal-title":"Eur. Biophys. J."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"11138","DOI":"10.1016\/S0021-9258(19)78102-2","article-title":"Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues","volume":"269","author":"Kiarash","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00731490","article-title":"Influence of phospholipid chain length on verotoxin\/globotriaosyl ceramide binding in model membranes: Comparison of a surface bilayer film and liposomes","volume":"13","author":"Arab","year":"1996","journal-title":"Glycoconj. J."},{"key":"ref_111","first-page":"405","article-title":"Differential carbohydrate epitope recognition of globotriaosyl ceramide by verotoxins and a monoclonal antibody. Role in human renal glomerular binding","volume":"271","author":"Chark","year":"2004","journal-title":"JBIC J. Biol. Inorg. Chem."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jim.2011.06.014","article-title":"Comparison of detection methods for cell surface globotriaosylceramide","volume":"371","author":"Kim","year":"2011","journal-title":"J. Immunol. Methods"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1172\/JCI37338","article-title":"The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice","volume":"119","author":"Greenshields","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0141-8130(05)80087-X","article-title":"Steric presentation and recognition of the saccharide chains of glycolipids at the cell surface: Favoured conformations of the saccharide-lipid linkage calculated using molecular mechanics (MM3)","volume":"15","author":"Nyholm","year":"1993","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/096876899294607","article-title":"Detergent-insoluble glycosphingolipid\/cholesterol-rich membrane domains, lipid rafts and caveolae (Review)","volume":"16","author":"Hooper","year":"1999","journal-title":"Mol. Membr. Biol."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Yahi, N., Aulas, A., and Fantini, J. (2010). How cholesterol constrains glycolipid conformation for optimal recognition of Alzheimer\u2019s beta amyloid peptide (Abeta1-40). PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009079"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nchembio.551","article-title":"Cholesterol modulates glycolipid conformation and receptor activity","volume":"7","author":"Lingwood","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"36049","DOI":"10.1074\/jbc.M110.110189","article-title":"A Major Fraction of Glycosphingolipids in Model and Cellular Cholesterol-containing Membranes Is Undetectable by Their Binding Proteins","volume":"285","author":"Mahfoud","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/S0022-2275(20)34940-3","article-title":"Use of cyclodextrins for manipulating cellular cholesterol content","volume":"38","author":"Haynes","year":"1997","journal-title":"J. Lipid Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"119440","DOI":"10.1016\/j.ijpharm.2020.119440","article-title":"Recent advances in the treatment of Niemann pick disease type C: A mini-review","volume":"584","author":"Matencio","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/glycob\/cwt059","article-title":"Cholesterol masks membrane glycosphingolipid tumor-associated antigens to reduce their immunodetection in human cancer biopsies","volume":"23","author":"Novak","year":"2013","journal-title":"Glycobiology"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/jcb.240350407","article-title":"Human teratocarcinoma stem cells: Glycolipid antigen expression and modulation during differentiation","volume":"35","author":"Andrews","year":"1987","journal-title":"J. Cell. Biochem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1182\/blood-2005-11-010504","article-title":"SSEA-4 identifies mesenchymal stem cells from bone marrow","volume":"109","author":"Gang","year":"2006","journal-title":"Blood"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/B:GLYC.0000043746.77504.28","article-title":"Carbohydrate antigens expressed on stem cells and early embryonic cells","volume":"21","author":"Muramatsu","year":"2004","journal-title":"Glycoconj. J."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1073\/pnas.1222649110","article-title":"Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer","volume":"110","author":"Huang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.stem.2009.03.003","article-title":"SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma","volume":"4","author":"Son","year":"2009","journal-title":"Cell Stem Cell"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"37195","DOI":"10.1074\/jbc.M112.396390","article-title":"Ceramide Glycosylation by Glucosylceramide Synthase Selectively Maintains the Properties of Breast Cancer Stem Cells","volume":"287","author":"Gupta","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1073\/pnas.1302825110","article-title":"Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells","volume":"110","author":"Liang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Begicevic, R.-R., and Falasca, M. (2017). ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18112362"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.1074\/jbc.275.9.6246","article-title":"Transfection of MDCK cells with the MDR1 gene results in a major increase in globotriaosyl ceramide and cell sensitivity to verocytotoxin: Role of P-gp in glycolipid biosynthesis","volume":"275","author":"Lala","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0925-4439(00)00011-9","article-title":"Apparent cooperativity in multivalent verotoxin globotriaosyl ceramide binding: Kinetic and saturation binding experiments with radiolabelled verotoxin [125I]-VT1","volume":"1501","author":"Peter","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Gallegos, K.M., Conrady, D.G., Karve, S.S., Gunasekera, T.S., Herr, A.B., and Weiss, A.A. (2012). Shiga Toxin Binding to Glycolipids and Glycans. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0030368"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1002\/anie.200701270","article-title":"Shiga toxin-mediated retrograde delivery of a topoisomerase I inhibitor prodrug","volume":"46","author":"Schmidt","year":"2007","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1021\/bc7003999","article-title":"Retrograde delivery of photosensitizer (TPPp-O-beta-GluOH)3 selectively potentiates its photodynamic activity","volume":"19","author":"Amessou","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ejmech.2015.03.047","article-title":"A new delivery system for auristatin in STxB-drug conjugate therapy","volume":"95","author":"Batisse","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/jcp.21456","article-title":"Differential Intracellular Trafficking and Binding of Verotoxin 1 and Verotoxin 2 to Globotriaosylceramide-containing Lipid Assemblies","volume":"216","author":"Tam","year":"2008","journal-title":"J. Cell Physiol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1047-8477(02)00504-X","article-title":"Two-dimensional structures of the Shiga toxin B-subunit and of a chimera bound to the glycolipid receptor Gb3","volume":"139","author":"Hagnerelle","year":"2002","journal-title":"J. Struct. Biol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.4049\/jimmunol.165.6.3301","article-title":"The B Subunit of Shiga Toxin Fused to a Tumor Antigen Elicits CTL and Targets Dendritic Cells to Allow MHC Class I-Restricted Presentation of Peptides Derived from Exogenous Antigens","volume":"165","author":"Haicheur","year":"2000","journal-title":"J. Immunol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/cmdc.200800249","article-title":"Synthesis and properties of a mitochondrial peripheral benzodiazepine receptor conjugate","volume":"3","author":"Schmidt","year":"2008","journal-title":"Chem. Med. Chem."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Patel, C., Saad, H., Shenkman, M., and Lederkremer, G.Z. (2020). Oxidoreductases in Glycoprotein Glycosylation, Folding, and ERAD. Cells, 9.","DOI":"10.3390\/cells9092138"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.biotechadv.2018.02.005","article-title":"Intracellular drug delivery: Potential usefulness of engineered Shiga toxin subunit B for targeted cancer therapy","volume":"36","author":"Luginbuehl","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.bbrc.2015.07.122","article-title":"Shiga-like toxin-based high-efficiency and receptor-specific intracellular delivery system for a protein","volume":"464","author":"Ryou","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/bit.25935","article-title":"Engineering of bacterial exotoxins for highly efficient and receptor-specific intracellular delivery of diverse cargos","volume":"113","author":"Ryou","year":"2016","journal-title":"Biotechnol. Bioeng."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Plavec, T., Zahirovi\u0107, A., Zadravec, P., Saboti\u010d, J., and Berlec, A. (2021). Lectin-Mediated Binding of Engineered Lactococcus lactis to Cancer Cells. Microorganisms, 9.","DOI":"10.3390\/microorganisms9020223"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"305","DOI":"10.30699\/IJP.2019.101200.2004","article-title":"Designing and Analyzing the Structure of DT-STXB Fusion Protein as an Anti-tumor Agent: An in Silico Approach","volume":"14","author":"Halabian","year":"2019","journal-title":"Iran J. Pathol."},{"key":"ref_146","unstructured":"Karmali, M.A., and Goglio, A.G. (1994). Shiga toxin-endothelial cell interactions. Recent Advances in Verocytotoxin-Producing Eshcerichia Coli Infections, Elsevier."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/BF00868715","article-title":"Escherichia coli verotoxin binding to human paediatric glomerular mesangial cells","volume":"9","author":"Robinson","year":"1995","journal-title":"Pediatr. Nephrol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1099\/mic.0.2007\/006858-0","article-title":"Membrane cytosolic translocation of verotoxin A1 subunit in target cells","volume":"153","author":"Tam","year":"2007","journal-title":"Microbiology"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1038\/ki.2008.624","article-title":"Treatment options for HUS secondary to Escherichia coli O157:H7","volume":"75","author":"Bitzan","year":"2009","journal-title":"Kidney Int."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1086\/338115","article-title":"Escherichia coli harboring Shiga toxin 2 gene varients:frequency and association with clinical symptoms","volume":"185","author":"Friedrich","year":"2002","journal-title":"J. Infect. Dis."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-2006-939766","article-title":"New Aspects in the Pathogenesis of Enteropathic Hemolytic Uremic Syndrome","volume":"32","author":"Karch","year":"2006","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0002-9440(10)65380-1","article-title":"Characterization of the Baboon Responses to Shiga-Like Toxin","volume":"154","author":"Taylor","year":"1999","journal-title":"Am. J. Pathol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1681\/ASN.V1271458","article-title":"Response to Single and Divided Doses of Shiga Toxin-1 in a Primate Model of Hemolytic Uremic Syndrome","volume":"12","author":"Siegler","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00467-002-1035-7","article-title":"Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome","volume":"18","author":"Siegler","year":"2003","journal-title":"Pediatr. Nephrol."},{"key":"ref_155","first-page":"1363","article-title":"Synergistic effect of verotoxin and interferon-alpha on erythropoiesis","volume":"49","author":"Maloney","year":"2003","journal-title":"Cell. Mol. Boil."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/cmi.12592","article-title":"Shiga toxin of enterohaemorrhagic Escherichia coli directly injures developing human erythrocytes","volume":"18","author":"Betz","year":"2016","journal-title":"Cell. Microbiol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2249.2000.01103.x","article-title":"Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality","volume":"119","author":"Palermo","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1128\/IAI.72.5.2618-2627.2004","article-title":"Regulation of Proinflammatory Cytokine Expression by Shiga Toxin 1 and\/or Lipopolysaccharides in the Human Monocytic Cell Line THP-1","volume":"72","author":"Harrison","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/infdis\/173.5.1164","article-title":"Comparison of the effects of Shiga-like toxin 1 on cytokine-and butyrate pretreated human umbilical and saphenous vein endothelial cells","volume":"173","author":"Keusch","year":"1996","journal-title":"J. Infect. Dis."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1128\/iai.65.8.3337-3344.1997","article-title":"Sensitization of human umbilical vein endothelial cells to Shiga toxin: Involvement of protein kinase C and NF-kappaB","volume":"65","author":"Louise","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1365-2141.2001.02835.x","article-title":"Interaction of cytokines and growth factor in the regulation of verotoxin-induced apoptosis in cultured human endothelial cells","volume":"113","author":"Molostvov","year":"2001","journal-title":"Br. J. Haematol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1128\/IAI.01300-07","article-title":"p38 Mitogen-Activated Protein Kinase Mediates Lipopolysaccharide and Tumor Necrosis Factor Alpha Induction of Shiga Toxin 2 Sensitivity in Human Umbilical Vein Endothelial Cells","volume":"76","author":"Stone","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1086\/344053","article-title":"Molecular Basis for Up-Regulation by Inflammatory Cytokines of Shiga Toxin 1 Cytotoxicity and Globotriaosylceramide Expression","volume":"186","author":"Stricklett","year":"2002","journal-title":"J. Infect. Dis."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1159\/000088523","article-title":"Lipopolysaccharide Upregulates Renal Shiga Toxin Receptors in a Primate Model of Hemolytic Uremic Syndrome","volume":"25","author":"Clayton","year":"2005","journal-title":"Am. J. Nephrol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/sj.ki.5001989","article-title":"Trafficking of Shiga toxin\/Shiga-like toxin-1 in human glomerular microvascular endothelial cells and human mesangial cells","volume":"70","author":"Warnier","year":"2006","journal-title":"Kidney Int."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/107999099313929","article-title":"Augmentation of Verotoxin-Induced Cytotoxicity\/Apoptosis by Interferon Is Repressed in Cells Persistently Infected with Mumps Virus","volume":"19","author":"Hariya","year":"1999","journal-title":"J. Interf. Cytokine Res."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1159\/000046288","article-title":"Response to Shiga Toxin-1, with and without Lipopolysaccharide, in a Primate Model of Hemolytic Uremic Syndrome","volume":"21","author":"Siegler","year":"2001","journal-title":"Am. J. Nephrol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1182\/blood.V88.1.174.174","article-title":"Effects of verocytotoxin-1 on nonadherent human monocytes: Binding characteristics, protein synthesis, and induction of cytokine release","volume":"88","author":"Monnens","year":"1996","journal-title":"Blood"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1128\/IAI.68.9.5183-5189.2000","article-title":"Shiga Toxin-Induced Tumor Necrosis Factor Alpha Expression: Requirement for Toxin Enzymatic Activity and Monocyte Protein Kinase C and Protein Tyrosine Kinases","volume":"68","author":"Foster","year":"2000","journal-title":"Infect. Immun."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1128\/AAC.46.11.3478-3483.2002","article-title":"Effects of Azithromycin on Shiga Toxin Production by Escherichia coli and Subsequent Host Inflammatory Response","volume":"46","author":"Ohara","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2353\/ajpath.2006.050959","article-title":"Elevated Levels of Cholesterol-Rich Lipid Rafts in Cancer Cells Are Correlated with Apoptosis Sensitivity Induced by Cholesterol-Depleting Agents","volume":"168","author":"Li","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00467-018-3903-9","article-title":"Eculizumab treatment in severe pediatric STEC-HUS: A multicenter retrospective study","volume":"33","author":"Percheron","year":"2018","journal-title":"Pediatr. Nephrol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s42003-021-02068-3","article-title":"Identification of a peptide motif that potently inhibits two functionally distinct subunits of Shiga toxin","volume":"4","author":"Tamada","year":"2021","journal-title":"Commun. Biol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"7230","DOI":"10.1158\/0008-5472.CAN-06-0631","article-title":"In vivo Tumor Targeting Using a Novel Intestinal Pathogen-Based Delivery Approach","volume":"66","author":"Janssen","year":"2006","journal-title":"Cancer Res."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1002\/(SICI)1521-4141(199910)29:10<3236::AID-IMMU3236>3.0.CO;2-T","article-title":"The extrafollicular-to-follicular transition of human B lymphocytes: Induction of functional globotriaosylceramide (CD77) on high threshold occupancy of CD40","volume":"29","author":"McCloskey","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/eji.200535443","article-title":"The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity","volume":"36","author":"Vingert","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1002\/(SICI)1521-4141(199809)28:09<2726::AID-IMMU2726>3.0.CO;2-W","article-title":"Major histocompatibility complex class I presentation of exogenous soluble tumor antigen fused to the B-fragment of Shiga toxin","volume":"28","author":"Lee","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0014-5793(99)00609-2","article-title":"Exploiting retrograde transport of Shiga-like toxin 1 for the delivery of exogenous antigens into the MHC class I presentation pathway","volume":"453","author":"Noakes","year":"1999","journal-title":"FEBS Lett."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.semcdb.2009.12.013","article-title":"ER quality control in the biogenesis of MHC class I molecules","volume":"21","author":"Chapman","year":"2010","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.4049\/jimmunol.179.5.3371","article-title":"B Subunit of Shiga Toxin-Based Vaccines Synergize with \u03b1-Galactosylceramide to Break Tolerance against Self Antigen and Elicit Antiviral Immunity","volume":"179","author":"Adotevi","year":"2007","journal-title":"J. Immunol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1158\/1078-0432.CCR-16-0044","article-title":"A Therapeutic Her2\/neu Vaccine Targeting Dendritic Cells Preferentially Inhibits the Growth of Low Her2\/neu-Expressing Tumor in HLA-A2 Transgenic Mice","volume":"22","author":"Tran","year":"2016","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1034\/j.1600-0854.2002.31001.x","article-title":"1st Class Ticket to Class I: Protein Toxins as Pathfinders for Antigen Presentation","volume":"3","author":"Smith","year":"2002","journal-title":"Traffic"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"172ra20","DOI":"10.1126\/scitranslmed.3004888","article-title":"Mucosal Imprinting of Vaccine-Induced CD8+ T Cells Is Crucial to Inhibit the Growth of Mucosal Tumors","volume":"5","author":"Sandoval","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"15221","DOI":"10.1038\/ncomms15221","article-title":"Induction of resident memory T cells enhances the efficacy of cancer vaccine","volume":"8","author":"Nizard","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1523-1755.2002.00502.x","article-title":"Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model","volume":"62","author":"Rutjes","year":"2002","journal-title":"Kidney Int."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1023\/A:1018578829997","article-title":"Establishment of a monoclonal antibody directed against Gb3Cer\/CD77: A useful immunochemical reagent for a differentiation marker in Burkitt\u2019s lymphoma and germinal centre B cells","volume":"14","author":"Miyamoto","year":"1997","journal-title":"Glycoconj. J."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0161-5890(95)00004-X","article-title":"The fate of human CD77+ germinal center B lymphocytes after rescue from apoptosis","volume":"32","author":"Mangeney","year":"1995","journal-title":"Mol. Immunol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1074-7613(00)80432-X","article-title":"Within Germinal Centers, Isotype Switching of Immunoglobulin Genes Occurs after the Onset of Somatic Mutation","volume":"4","author":"Liu","year":"1996","journal-title":"Immunity"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/intimm\/2.1.1","article-title":"Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: A mechanism for the failure of long-lived antibody response to dysenteric disease","volume":"2","author":"Cohen","year":"1990","journal-title":"Int. Immunol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.ijmm.2018.06.013","article-title":"Human monocytes stimulated by Shiga toxin 1a via globotriaosylceramide release proinflammatory molecules associated with hemolytic uremic syndrome","volume":"308","author":"Brigotti","year":"2018","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1189\/jlb.0709475","article-title":"Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration","volume":"88","author":"Brigotti","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"eabc0217","DOI":"10.1126\/sciimmunol.abc0217","article-title":"Shiga toxin suppresses noncanonical inflammasome responses to cytosolic LPS","volume":"5","author":"Havira","year":"2020","journal-title":"Sci. Immunol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbrc.2021.04.015","article-title":"A nontoxigenic form of Shiga toxin 2 suppresses the production of amyloid \u03b2 by altering the intracellular transport of amyloid precursor protein through its receptor-binding B-subunit","volume":"557","author":"Sato","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.1128\/IAI.71.10.6075-6078.2003","article-title":"Serum Amyloid P Component Binding to Shiga Toxin 2 Requires Both A Subunit and B Pentamer","volume":"71","author":"Marcato","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"10392","DOI":"10.1074\/jbc.270.18.10392","article-title":"Ca(2+)-dependent binding of human serum amyloid P component to Alzheimer\u2019s beta-amyloid peptide","volume":"270","author":"Hamazaki","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1006\/bbrc.1995.1819","article-title":"Amyloid P component promotes aggregation of Alzheimer\u2019s beta-amyloid peptide","volume":"211","author":"Hamazaki","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1073\/pnas.92.10.4299","article-title":"Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis","volume":"92","author":"Tennent","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_198","first-page":"254","article-title":"Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis","volume":"417","author":"Pepys","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1091\/mbc.e11-04-0332r","article-title":"Cholesterol transport from late endosomes to the Golgi regulates t-SNARE trafficking, assembly and function","volume":"22","author":"Reverter","year":"2011","journal-title":"Mol. Biol. Cell."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fcimb.2020.00123","article-title":"Verotoxin Receptor-Based Pathology and Therapies","volume":"10","author":"Lingwood","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1091\/mbc.e05-02-0100","article-title":"Cholesterol Is Required for Efficient Endoplasmic Reticulum-to-Golgi Transport of Secretory Membrane Proteins","volume":"17","author":"Ridsdale","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0962-8924(02)02399-1","article-title":"Endocytosis and sorting of glycosphingolipids in sphingolipid storage disease","volume":"12","author":"Marks","year":"2002","journal-title":"Trends Cell Biol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"20961","DOI":"10.1074\/jbc.M300304200","article-title":"Sphingolipid Storage Induces Accumulation of Intracellular Cholesterol by Stimulating SREBP-1 Cleavage","volume":"278","author":"Puri","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"483","DOI":"10.34297\/AJBSR.2020.07.001206","article-title":"Is Cholesterol the Key Factor for Autism?","volume":"7","author":"Lingwood","year":"2020","journal-title":"Am. J. Biomed. Sci. Res."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1111\/j.1742-4658.2006.05562.x","article-title":"The minimal amyloid-forming fragment of the islet amyloid polypeptide is a glycolipid-binding domain","volume":"273","author":"Levy","year":"2006","journal-title":"FEBS J."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1021\/cn300203a","article-title":"Biochemical identification of a linear cholesterol-binding domain within Alzheimer\u2019s beta amyloid peptide","volume":"4","author":"Yahi","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fphys.2013.00120","article-title":"Cholesterol accelerates the binding of Alzheimer\u2019s beta-amyloid peptide to ganglioside GM1 through a universal hydrogen-bond-dependent sterol tuning of glycolipid conformation","volume":"4","author":"Fantini","year":"2013","journal-title":"Front. Physiol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"28110","DOI":"10.1074\/jbc.M414525200","article-title":"Inhibition of glycosphingolipid biosynthesis reduces secretion of the beta-amyloid precursor protein and amyloid beta-peptide","volume":"280","author":"Tamboli","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"36815","DOI":"10.1074\/jbc.M504484200","article-title":"Lipids as modulators of proteolytic activity of BACE: Involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro","volume":"280","author":"Kalvodova","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"a033928","DOI":"10.1101\/cshperspect.a033928","article-title":"Chaperoning Endoplasmic Reticulum\u2013Associated Degradation (ERAD) and Protein Conformational Diseases","volume":"11","author":"Needham","year":"2019","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1006\/scdb.1999.0318","article-title":"Role and regulation of the ER chaperone BiP","volume":"10","author":"Gething","year":"1999","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1242\/jcs.02856","article-title":"Beyond lectins: The calnexin\/calreticulin chaperone system of the endoplasmic reticulum","volume":"119","author":"Williams","year":"2006","journal-title":"J. Cell Sci."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1091\/mbc.e11-08-0704","article-title":"Protein disulfide isomerases contribute differentially to the endoplasmic reticulum\u2013associated degradation of apolipoprotein B and other substrates","volume":"23","author":"Grubb","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.freeradbiomed.2014.08.012","article-title":"Regulation of protein turnover by heat shock proteins","volume":"77","author":"Bozaykut","year":"2014","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0300-9084(01)01244-5","article-title":"The unfolding of substrates and ubiquitin-independent protein degradation by proteasomes","volume":"83","author":"Benaroudj","year":"2001","journal-title":"Biochimie"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/cells3030824","article-title":"Regulation of Endoplasmic Reticulum-Associated Protein Degradation (ERAD) by Ubiquitin","volume":"3","author":"Lemus","year":"2014","journal-title":"Cells"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.semcdb.2009.12.007","article-title":"ERAD substrates: Which way out?","volume":"21","author":"Hebert","year":"2010","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"079","DOI":"10.1385\/1-59259-822-6:079","article-title":"Protein Degradation Via the Proteosome","volume":"285","author":"Hoff","year":"2004","journal-title":"Cell Cycle Control Dysregulation Protoc."},{"key":"ref_219","first-page":"1684","article-title":"The degradation of mutant proteins by ERAD and the pathogenesis of diseases","volume":"28","author":"Osaki","year":"2018","journal-title":"Clin. Calcium"},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Adnan, H., Zhang, Z., Park, H.-J., Tailor, C., Che, C., Kamani, M., Spitalny, G., Binnington, B., and Lingwood, C. (2016). Endoplasmic Reticulum-Targeted Subunit Toxins Provide a New Approach to Rescue Misfolded Mutant Proteins and Revert Cell Models of Genetic Diseases. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0166948"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejmech.2014.11.002","article-title":"Conformationally-locked N-glycosides: Exploiting long-range non-glycone interactions in the design of pharmacological chaperones for Gaucher disease","volume":"90","author":"Castilla","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ejmech.2019.07.037","article-title":"An overview on chemical structures as DeltaF508-CFTR correctors","volume":"180","author":"Spano","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1128\/MCB.25.12.5242-5252.2005","article-title":"Most F508del-CFTR Is Targeted to Degradation at an Early Folding Checkpoint and Independently of Calnexin","volume":"25","author":"Farinha","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1074\/jbc.M009172200","article-title":"Conformational and temperature-sensitive stability defects of the delta F508 cystic fibrosis transmembrane conductance regulator in post-endoplasmic reticulum compartments","volume":"276","author":"Sharma","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"35825","DOI":"10.1074\/jbc.M110.131623","article-title":"The cystic fibrosis-causing mutation deltaF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis","volume":"285","author":"Thibodeau","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1083\/jcb.200312018","article-title":"Misfolding diverts CFTR from recycling to degradation: Quality control at early endosomes","volume":"164","author":"Sharma","year":"2004","journal-title":"J. Cell Biol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"7189","DOI":"10.1074\/jbc.273.13.7189","article-title":"Cotranslational Ubiquitination of Cystic Fibrosis Transmembrane Conductance Regulator in Vitro","volume":"273","author":"Sato","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.bbadis.2010.08.001","article-title":"Functional analysis of F508del CFTR in native human colon","volume":"1802","author":"Stanke","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/humu.22124","article-title":"Gaucher disease paradigm: From ERAD to co-morbidity","volume":"33","author":"Horowitz","year":"2012","journal-title":"Hum. Mutat."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher\u2019s disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1002\/j.1460-2075.1995.tb00119.x","article-title":"A mouse model for the cystic fibrosis delta F508 mutation","volume":"14","author":"French","year":"1995","journal-title":"Embo J."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1172\/JCI118253","article-title":"A mouse model for the delta F508 allele of cystic fibrosis","volume":"96","author":"Zeiher","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1113\/expphysiol.2004.028720","article-title":"Salivary secretion assay for drug efficacy for cystic fibrosis in mice","volume":"90","author":"Best","year":"2005","journal-title":"Exp. Physiol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jcf.2013.05.001","article-title":"Modification of the salivary secretion assay in F508del mice\u2014The murine equivalent of the human sweat test","volume":"12","author":"Droebner","year":"2013","journal-title":"J. Cyst. Fibros."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fphar.2012.00176","article-title":"Ouabain Mimics Low Temperature Rescue of F508del-CFTR in Cystic Fibrosis Epithelial Cells","volume":"3","author":"Zhang","year":"2012","journal-title":"Front. Pharmacol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1242\/bio.010967","article-title":"Resveratrol increases F508del-CFTR dependent salivary secretion in cystic fibrosis mice","volume":"4","author":"Dhooghe","year":"2015","journal-title":"Biol. Open"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcf.2014.06.001","article-title":"Ibuprofen rescues mutant cystic fibrosis transmembrane conductance regulator trafficking","volume":"14","author":"Carlile","year":"2015","journal-title":"J. Cyst. Fibros."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bcmd.2013.03.006","article-title":"Transgenic mice expressing human glucocerebrosidase variants: Utility for the study of Gaucher disease","volume":"51","author":"Sanders","year":"2013","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1182\/blood-2011-05-352971","article-title":"Elevated plasma glucosylsphingosine in Gaucher disease: Relation to phenotype, storage cell markers, and therapeutic response","volume":"118","author":"Dekker","year":"2011","journal-title":"Blood"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/jimd.12192","article-title":"Expanding the clinical utility of glucosylsphingosine for Gaucher disease","volume":"43","author":"Saville","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_241","doi-asserted-by":"crossref","unstructured":"Revel-Vilk, S., Fuller, M., and Zimran, A. (2020). Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21197159"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1093\/hmg\/ddi259","article-title":"ER-associated protein degradation is a common mechanism underpinning numerous monogenic diseases including Robinow syndrome","volume":"14","author":"Chen","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fmicb.2014.00330","article-title":"ERAD and how viruses exploit it","volume":"5","author":"Byun","year":"2014","journal-title":"Front. Microbiol."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/excr.2001.5297","article-title":"A Verotoxin 1 B Subunit-Lambda CRO Chimeric Protein Specifically Binds Both DNA and Globotriaosylceramide (Gb3) to Effect Nuclear Targeting of Exogenous DNA in Gb3 Positive Cells","volume":"269","author":"Facchini","year":"2001","journal-title":"Exp. Cell Res."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/13\/6\/378\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:07:54Z","timestamp":1760162874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/13\/6\/378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,26]]},"references-count":244,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["toxins13060378"],"URL":"https:\/\/doi.org\/10.3390\/toxins13060378","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,26]]}}}